145 related articles for article (PubMed ID: 12383958)
21. Effects of NMDA and MK-801 injected into the substantia nigra pars reticulata on jaw movements evoked by dopamine D1-/D2 receptor stimulation in the ventrolateral striatum: studies in freely moving rats.
Uchida T; Lee J; Fujita S; Kiguchi M; Matsumoto M; Oi Y; Gionhaku N; Koshikawa N
Methods Find Exp Clin Pharmacol; 2005; 27(1):31-7. PubMed ID: 15834457
[TBL] [Abstract][Full Text] [Related]
22. Monoamine release in the rat striatum is induced by delta-guanidinovaleric acid and inhibited by GABA agonists.
Kabuto H; Yokoi I; Iwaya K; Mori A
Life Sci; 1995; 56(20):1741-8. PubMed ID: 7723603
[TBL] [Abstract][Full Text] [Related]
23. Effects of GABAergic drugs on the GABA turnover in the substantia nigra and the corpus striatum of the rat.
Lindgren S
J Neural Transm; 1987; 69(1-2):33-46. PubMed ID: 3035084
[TBL] [Abstract][Full Text] [Related]
24. The substantia nigra pars reticulata mediates the enhancement of startle by the dopamine D1 receptor agonist SKF 82958 in rats.
Meloni EG; Davis M
Psychopharmacology (Berl); 2004 Jul; 174(2):228-36. PubMed ID: 14735289
[TBL] [Abstract][Full Text] [Related]
25. A review of recent neurochemical data on inert gas narcosis.
Rostain JC; Lavoute C; Risso JJ; Vallée N; Weiss M
Undersea Hyperb Med; 2011; 38(1):49-59. PubMed ID: 21384763
[TBL] [Abstract][Full Text] [Related]
26. Nitrous oxide reverses the increase in striatal dopamine release produced by N-methyl-D-aspartate infusion in the substantia nigra pars compacta in rats.
Balon N; Dupenloup L; Blanc F; Weiss M; Rostain JC
Neurosci Lett; 2003 Jun; 343(2):147-9. PubMed ID: 12759185
[TBL] [Abstract][Full Text] [Related]
27. Distinct mechanisms of presynaptic inhibition at GABAergic synapses of the rat substantia nigra pars compacta.
Giustizieri M; Bernardi G; Mercuri NB; Berretta N
J Neurophysiol; 2005 Sep; 94(3):1992-2003. PubMed ID: 15944237
[TBL] [Abstract][Full Text] [Related]
28. The role of GABA receptors in the control of nigrostriatal dopaminergic neurons: dual-probe microdialysis study in awake rats.
Santiago M; Westerink BH
Eur J Pharmacol; 1992 Aug; 219(2):175-81. PubMed ID: 1330605
[TBL] [Abstract][Full Text] [Related]
29. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
Hossain MA; Weiner N
J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
[TBL] [Abstract][Full Text] [Related]
30. Motor activity-induced dopamine release in the substantia nigra is regulated by muscarinic receptors.
Andersson DR; Björnsson E; Bergquist F; Nissbrandt H
Exp Neurol; 2010 Jan; 221(1):251-9. PubMed ID: 19944096
[TBL] [Abstract][Full Text] [Related]
31. Sex-specific KCC2 expression and GABA(A) receptor function in rat substantia nigra.
Galanopoulou AS; Kyrozis A; Claudio OI; Stanton PK; Moshé SL
Exp Neurol; 2003 Oct; 183(2):628-37. PubMed ID: 14552904
[TBL] [Abstract][Full Text] [Related]
32. Dopamine action in the substantia nigra pars reticulata: iontophoretic studies in awake, unrestrained rats.
Windels F; Kiyatkin EA
Eur J Neurosci; 2006 Sep; 24(5):1385-94. PubMed ID: 16987223
[TBL] [Abstract][Full Text] [Related]
33. Effects of NMDA administration in the substantia nigra pars compacta on the striatal dopamine release before and after repetitive exposures to nitrogen narcosis in rats.
Lavoute C; Weiss M; Rostain JC
Undersea Hyperb Med; 2006; 33(3):175-9. PubMed ID: 16869531
[TBL] [Abstract][Full Text] [Related]
34. Effects of muscimol and picrotoxin on single unit activity of substantia nigra neurons.
Waszczak BL; Eng N; Walters JR
Brain Res; 1980 Apr; 188(1):185-97. PubMed ID: 7370752
[TBL] [Abstract][Full Text] [Related]
35. Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release.
Heeringa MJ; Abercrombie ED
J Neurochem; 1995 Jul; 65(1):192-200. PubMed ID: 7790860
[TBL] [Abstract][Full Text] [Related]
36. Transsynaptic effect of an intrastriatal fetal nigral graft on the sensitivity of the substantia nigra pars reticulata to muscimol in the rat.
Gaudin DP; St-Pierre JA; Lavoie B; Bédard PJ
Exp Neurol; 1994 May; 127(1):45-53. PubMed ID: 8200436
[TBL] [Abstract][Full Text] [Related]
37. Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation.
Proença MB; Dombrowski PA; Da Cunha C; Fischer L; Ferraz AC; Lima MM
Neuropharmacology; 2014 Jan; 76 Pt A():118-26. PubMed ID: 24012539
[TBL] [Abstract][Full Text] [Related]
38. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
Yamamoto BK; Nash JF; Gudelsky GA
J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
[TBL] [Abstract][Full Text] [Related]
39. Post effect of repetitive exposures to pressure nitrogen-induced narcosis on the dopaminergic activity at atmospheric pressure.
Lavoute C; Weiss M; Sainty JM; Risso JJ; Rostain JC
Undersea Hyperb Med; 2008; 35(1):21-5. PubMed ID: 18351123
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of somatodendritic and nerve terminal dopamine release by serotonergic innervation of substantia nigra.
Cobb WS; Abercrombie ED
J Neurochem; 2003 Feb; 84(3):576-84. PubMed ID: 12558977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
